Multiple sclerosis: improvement of visuoperceptive functions by picoTesla range magnetic fields

scientific article published in January 1994

Multiple sclerosis: improvement of visuoperceptive functions by picoTesla range magnetic fields is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/00207459408987238
P698PubMed publication ID7928104

P2093author name stringSandyk R
Iacono RP
P2860cites workDeficient learning and memory in early and middle phases of multiple sclerosisQ33619519
Neuropsychological syndromes in presenile dementia due to cerebral atrophyQ33621936
Sleep induced by the administration of melatonin (5-methoxy-N-acetyltryptamine) to the hypothalamus in unrestrained catsQ51271704
A comparison of dementia in Alzheimer's disease and multiple sclerosis.Q52066615
On drawing impairment in Alzheimer's disease.Q52102002
Melatonin: Effects on brain and behaviorQ52105997
Intellectual impairment in multiple sclerosis and its relation to functional abilitiesQ52106712
Memory disturbance in chronic progressive multiple sclerosis.Q52210743
Cognitive functioning in multiple sclerosis.Q52265827
Asymmetrical cognitive deterioration in demented and Parkinson patients.Q52291302
Effects of an Earth-strength magnetic field on electrical activity of pineal cellsQ59063163
Reversible chronic cerebellar ataxia after phenytoin intoxication: possible role of cerebellum in cognitive thoughtQ34199212
Subcortical neglectQ34281363
Suppression of Human Growth Hormone Secretion by Melatonin and CyproheptadineQ34463534
Role of the cerebellum in complex human behaviorQ34541328
Cerebellar contributions to the Papez circuitQ34746184
Nocturnal Plasma Melatonin and Alpha-Melanocyte Stimulating Hormone Levels During Exacerbation of Multiple SclerosisQ35223138
Effects of melatonin on sleep and neurochemistry in the ratQ36123922
Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseasesQ36994104
Monoamine metabolites in cerebrospinal fluid in multiple sclerosisQ37054783
Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosisQ37100307
Emotional and cognitive correlates of multiple sclerosis.Q37848563
Cognitive loss in multiple sclerosis. Case reports and review of the literatureQ38602567
The distribution of plaques in the cerebrum in multiple sclerosisQ39412145
Geomagnetic field detection in rodentsQ39627574
Neuropsychology of multiple sclerosis: a critical reviewQ39801476
Neuropeptide MSH/ACTH 4–10 enhances attention in the mentally retardedQ40043520
The opiomelanotropinergic neuronal and endocrine systemsQ40131246
Effects of MSH/ACTH 4–10 on memory, attention and endogenous hormone levels in women☆Q40142341
Specific Binding of Melatonin in Bovine Brain*Q40237755
Melatonin receptors in brainQ40237903
Diurnal changes in melatonin binding sites of hamster and rat brains. Correlation with neuroendocrine responsiveness to melatoninQ40287154
A cortical network for directed attention and unilateral neglectQ40321279
The role of melatonin and serotonin in agingQ41345262
Brain autoradiographic study in the golden hamster after intracarotid injection of [14C]melatoninQ44243139
Dissociated neglect behavior following sequential strokes in the right hemisphereQ44286522
Anatomical features and physiological properties of central serotonin neuronsQ44393226
Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosisQ44885412
Influence of neonatal injections of alpha-MSH on learning, memory and attention in ratsQ45081095
Cerebral multiple sclerosisQ45238327
A controlled neuropsychological comparison of Huntington's disease and multiple sclerosisQ45297347
5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseasesQ45303241
MSH Activity in Plasma and Pituitaries of Rats After Various TreatmentsQ47804080
Melatonin Receptor Sites in the Syrian Hamster Brain and Pituitary. Localization and Characterization Using [|]lodomelatonin*.Q47838524
Ouabain-induced seizures in rats: modification by melatonin and melanocyte-stimulating hormoneQ47943774
Static magnetic fields decrease nocturnal pineal cAMP in the rat.Q48088601
Hypoarousal in patients with the neglect syndrome and emotional indifferenceQ48208286
Magnetic fields abolish nychthemeral rhythmicity of responses of Purkinje cells to the pineal hormone melatonin in the pigeon's cerebellumQ48265067
Differential localization of N-acetylated indolealkylamines in CNS and the Harderian gland using immunohistologyQ48343189
Growth Hormone Responses to Melatonin in ManQ48547163
Effects of melatonin on human mood and performanceQ48590556
Growth Hormone Regulation by Melatonin and SerotoninQ48642831
Interactions between pineal, hypothalamus, and pituitary involving melatonin, MSH release-inhibiting factor and MSH.Q48716113
Right thalamic injury, impaired visuospatial perception, and alexiaQ48968520
Psycho-physiologic correlates of MSH activity in manQ51116122
P433issue1-4
P921main subjectmultiple sclerosisQ8277
P1104number of pages13
P304page(s)177-189
P577publication date1994-01-01
P1433published inInternational Journal of NeuroscienceQ6051511
P1476titleMultiple sclerosis: improvement of visuoperceptive functions by picoTesla range magnetic fields
P478volume74

Reverse relations

cites work (P2860)
Q36681597Chronic relapsing multiple sclerosis: a case of rapid recovery by application of weak electromagnetic fields
Q38961506Extremely low frequency electromagnetic fields stimulation modulates autoimmunity and immune responses: a possible immuno-modulatory therapeutic effect in neurodegenerative diseases.
Q52000784Immediate recovery of cognitive functions and resolution of fatigue by treatment with weak electromagnetic fields in a patient with multiple sclerosis.
Q52056215Improvement in word-fluency performance in patients with multiple sclerosis by electromagnetic fields.
Q41069606Long term beneficial effects of weak electromagnetic fields in multiple sclerosis
Q41163507Premenstrual exacerbation of symptoms in multiple sclerosis is attenuated by treatment with weak electromagnetic fields
Q41069613Reversal of alexia in multiple sclerosis by weak electromagnetic fields
Q48498380Treatment with electromagnetic fields improves dual-task performance (talking while walking) in multiple sclerosis

Search more.